A new era in hypertension research: discussing the findings of ALLHAT.

Curr Control Trials Cardiovasc Med · 2001 · PMC64822 · PMID 11806805

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

First, there was a highly significant (25%) excess risk of major cardiovascular events (a prespecified secondary endpoint) in the doxazosin group in comparison to the chlorthalidone group.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.